Signaling Pathway
Ravagalimab (ABBV-323) functions as a potent CD40 antagonist with an EC50 value of 3.7 nM. This monoclonal antibody is primarily utilized in the research of Crohn's disease, offering a valuable tool for investigating the pathophysiology and potential therapeutic interventions targeting the CD40 pathway in this condition.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Ravagalimab (ABBV-323) functions as a potent CD40 antagonist with an EC50 value of 3.7 nM. This monoclonal antibody is primarily utilized in the research of Crohn's disease, offering a valuable tool for investigating the pathophysiology and potential therapeutic interventions targeting the CD40 pathway in this condition. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
